Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

Saskatchewan Health Authority - Regina Area · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
antiretroviral-therapyopioid-use-disorder
hiv-1-infection, opioid use disorder, antiretroviral therapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 909345
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.